ERA - Leading European Nephrology

My ERA Join ERA

Home | Video pages | Webcast | Effects of canagliflozin versus finerenone on cardiorenal outcomes

Effects of canagliflozin versus finerenone on cardiorenal outcomes

Share

https://www.youtube.com/watch?v=eOD4qajQ8EI copy

Other e-seminars from this series

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the IWG of ERA

ERA Journal Club

Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease

ERA Journal Club

Aldosterone synthase inhibitors in CKD (and EASi-KIDNEY’s outline design)

ERA Journal Club

Epidemiological and clinicopathological characteristics of vascular-limited renal AL amyloidosis

ERA Journal Club

Kidney Transplantation in Patients with Polycystic Kidney Disease

ERA Journal Club

Post-transplant renal anaemia: a call to action from a national study in routine clinical practice

ERA Journal Club

Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension

ERA Journal Club

Using Artificial Intelligence to Predict Mortality in AKI Patients: A systematic review/Meta-Analysis

ERA Journal Club

Clinical impact of the Kidney Failure Risk Equation for vascular access planning

ERA Journal Club

Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

ERA Journal Club

Patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist

ERA Journal Club

Monoclonal gammopathy of unknown significance in kidney transplanted patients

ERA Journal Club